• 3489 Citations
  • 30 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 31 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Carboplatin Medicine & Life Sciences
irinotecan Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Pemetrexed Medicine & Life Sciences
Cisplatin Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1997 2018

1 Citations

24-Month Overall Survival from KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin with or without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous Non–Small Cell Lung Cancer

Borghaei, H., Langer, C. J., Gadgeel, S., Papadimitrakopoulou, V. A., Patnaik, A., Powell, S. F., Gentzler, R. D., Martins, R. G., Stevenson, J. P., Jalal, S. I., Panwalkar, A., Chih-Hsin Yang, J., Gubens, M., Sequist, L. V., Awad, M. M., Fiore, J., Saraf, S., Keller, S. M. & Gandhi, L., Jan 1 2018, (Accepted/In press) In : Journal of Thoracic Oncology.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
5 Citations

NCCN guidelines® insights non–small cell lung cancer, version 5.2018 featured updates to the NCCN guidelines

Ettinger, D. S., Aisner, D. L., Wood, D. E., Akerley, W., Bauman, J., Chang, J. Y., Chirieac, L. R., D’Amico, T. A., Dilling, T. J., Dobelbower, M., Govindan, R., Gubens, M. A., Hennon, M., Horn, L., Lackner, R. P., Lanuti, M., Leal, T. A., Lilenbaum, R., Lin, J., Loo, B. W. & 13 othersMartins, R., Otterson, G. A., Patel, S. P., Reckamp, K., Riely, G. J., Schild, S. E., Shapiro, T. A., Stevenson, J. P., Swanson, S. J., Tauer, K., Yang, S. C., Gregory, K. & Hughes, M., Jul 1 2018, In : JNCCN Journal of the National Comprehensive Cancer Network. 16, 7, p. 807-821 15 p.

Research output: Contribution to journalReview article

Non-Small Cell Lung Carcinoma

Pembrolizumab and platinum-based chemotherapy as first-line therapy for advanced non–small-cell lung cancer: Phase 1 cohorts from the KEYNOTE-021 study

Gadgeel, S. M., Stevenson, J. P., Langer, C. J., Gandhi, L., Borghaei, H., Patnaik, A., Villaruz, L. C., Gubens, M., Hauke, R., Yang, J. C. H., Sequist, L. V., Bachman, R., Saraf, S., Raftopoulos, H. & Papadimitrakopoulou, V., Nov 1 2018, In : Lung Cancer. 125, p. 273-281 9 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Drug Therapy
2 Citations

Phase II Study of Maintenance Pembrolizumab in Patients with Extensive-Stage Small Cell Lung Cancer (SCLC)

Gadgeel, S. M., Pennell, N. A., Fidler, M. J., Halmos, B., Bonomi, P., Stevenson, J. P., Schneider, B., Sukari, A., Ventimiglia, J., Chen, W., Galasso, C., Wozniak, A., Boerner, J. & Kalemkerian, G. P., Jan 1 2018, (Accepted/In press) In : Journal of Thoracic Oncology.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
Disease-Free Survival
Confidence Intervals

Post-treatment changes in hematological parameters predict response to nivolumab monotherapy in non-small cell lung cancer patients

Khunger, M., Patil, P. D., Khunger, A., Li, M., Hu, B., Rakshit, S., Basu, A., Pennell, N. A., Stevenson, J. P., Elson, P., Panchabhai, T. S. & Velcheti, V., Oct 1 2018, In : PloS one. 13, 10, e0197743.

Research output: Contribution to journalArticle

lung neoplasms
Non-Small Cell Lung Carcinoma